Cognition Therapeutics to Report Second Quarter 2024 Financial Results

Core Viewpoint - Cognition Therapeutics, Inc. is set to release its financial results for Q2 2024 on August 8, 2024, and will host a conference call to discuss these results and provide a business update [1]. Group 1: Financial Results Announcement - The financial results for the second quarter ended June 30, 2024, will be released before the market opens on August 8, 2024 [1]. - A conference call will take place at 8:30 a.m. ET on the same day to review the financial and operating results [1]. Group 2: Conference Call Details - The conference call can be accessed via a toll-free number for US/Canada participants: (800) 715-9871, and an international dial-in number: (646) 307-1963 [2]. - The conference ID number for the call is 3702003 [2]. - An audio webcast with live Q&A will be available, and an archive of the webcast will be accessible for 90 days starting at approximately 10:30 a.m. ET on August 8, 2024 [2]. Group 3: Company Overview - Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule therapeutics for age-related degenerative disorders of the central nervous system and retina [3]. - The company is investigating its lead candidate CT1812 in clinical programs for Alzheimer's disease, dementia with Lewy bodies, and dry age-related macular degeneration [3]. - CT1812 targets the σ-2 receptor, representing a distinct mechanism compared to other current treatment approaches for degenerative diseases [3].